Protara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Protara Therapeutics

05/05/2022 15:10

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 96 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 90 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of 96 cents​.
    * The mean earnings estimate of analysts had risen by
about 17.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Protara Therapeutics Inc shares had fallen by 32.5% this
quarter and lost 48.9% so far this year.
    * The company reported a quarterly loss of $10.76 million.
    * Wall Street's median 12-month price target for Protara
Therapeutics Inc is $39.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 02:10 p.m.  ​All
figures in US dollars unless otherwise stated